237 related articles for article (PubMed ID: 19585648)
101. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
Liu B; Li NL; Shen Y; Bao X; Fabrizio T; Elbahesh H; Webby RJ; Li K
J Virol; 2016 May; 90(9):4369-4382. PubMed ID: 26889027
[TBL] [Abstract][Full Text] [Related]
102. The cGAS-STING Defense Pathway and Its Counteraction by Viruses.
Ma Z; Damania B
Cell Host Microbe; 2016 Feb; 19(2):150-8. PubMed ID: 26867174
[TBL] [Abstract][Full Text] [Related]
103. Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus.
Liu B; Li NL; Wang J; Shi PY; Wang T; Miller MA; Li K
J Virol; 2014 Dec; 88(23):13821-35. PubMed ID: 25253338
[TBL] [Abstract][Full Text] [Related]
104. TRIM22 inhibits the TRAF6-stimulated NF-κB pathway by targeting TAB2 for degradation.
Qiu H; Huang F; Xiao H; Sun B; Yang R
Virol Sin; 2013 Aug; 28(4):209-15. PubMed ID: 23818111
[TBL] [Abstract][Full Text] [Related]
105. Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5'-UTR of
Lim KH; Park ES; Kim DH; Cho KC; Kim KP; Park YK; Ahn SH; Park SH; Kim KH; Kim CW; Kang HS; Lee AR; Park S; Sim H; Won J; Seok K; You JS; Lee JH; Yi NJ; Lee KW; Suh KS; Seong BL; Kim KH
Gut; 2018 Jan; 67(1):166-178. PubMed ID: 28341749
[TBL] [Abstract][Full Text] [Related]
106. Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.
Yang C; Zhao X; Sun D; Yang L; Chong C; Pan Y; Chi X; Gao Y; Wang M; Shi X; Sun H; Lv J; Gao Y; Zhong J; Niu J; Sun B
Cell Mol Immunol; 2016 Jan; 13(1):94-102. PubMed ID: 25683609
[TBL] [Abstract][Full Text] [Related]
107. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J
Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880
[TBL] [Abstract][Full Text] [Related]
108. E3 ubiquitin ligase TRIM21 restricts hepatitis B virus replication by targeting HBx for proteasomal degradation.
Song Y; Li M; Wang Y; Zhang H; Wei L; Xu W
Antiviral Res; 2021 Aug; 192():105107. PubMed ID: 34097931
[TBL] [Abstract][Full Text] [Related]
109. TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of Raf-1.
Fei X; Dou YN; Sun K; Wei J; Guo Q; Wang L; Wu X; Lv W; Jiang X; Fei Z
Exp Mol Med; 2023 Jun; 55(6):1203-1217. PubMed ID: 37258577
[TBL] [Abstract][Full Text] [Related]
110. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
[TBL] [Abstract][Full Text] [Related]
111. Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes.
Reddi TS; Merkl PE; Lim SY; Letvin NL; Knipe DM
PLoS Pathog; 2021 Feb; 17(2):e1009281. PubMed ID: 33524065
[TBL] [Abstract][Full Text] [Related]
112. TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis.
Zhang L; Zhang B; Wei M; Xu Z; Kong W; Deng K; Xu X; Zhang L; Ζhao X; Yan L
Int J Oncol; 2020 May; 56(5):1225-1239. PubMed ID: 32319602
[TBL] [Abstract][Full Text] [Related]
113. Tripartite Motif Containing 52 (TRIM52) Promotes Cell Proliferation in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Zhang Y; Wu SS; Chen XH; Tang ZH; Yu YS; Zang GQ
Med Sci Monit; 2017 Nov; 23():5202-5210. PubMed ID: 29089476
[TBL] [Abstract][Full Text] [Related]
114. Intracellular Host Restriction of Hepatitis B Virus Replication.
Sinha P; Thio CL; Balagopal A
Viruses; 2024 May; 16(5):. PubMed ID: 38793645
[TBL] [Abstract][Full Text] [Related]
115. SP140 inhibitor suppressing TRIM22 expression regulates glioma progress through PI3K/AKT signaling pathway.
Li X; Li G; Li L; Gao B; Niu X; Wang Y; Wang Z
Brain Behav; 2024 Mar; 14(3):e3465. PubMed ID: 38468469
[TBL] [Abstract][Full Text] [Related]
116. IFN-γ: A Crucial Player in the Fight Against HBV Infection?
Hillaire MLB; Lawrence P; Lagrange B
Immune Netw; 2023 Aug; 23(4):e30. PubMed ID: 37670813
[TBL] [Abstract][Full Text] [Related]
117. Cellular Factors Involved in the Hepatitis D Virus Life Cycle.
Thiyagarajah K; Basic M; Hildt E
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632029
[TBL] [Abstract][Full Text] [Related]
118. Interleukin-22 facilitates the interferon-λ-mediated production of tripartite motif protein 25 to inhibit replication of duck viral hepatitis A virus type 1.
An H; Liu Y; Shu M; Chen J
Vet Res; 2023 Jun; 54(1):53. PubMed ID: 37391858
[TBL] [Abstract][Full Text] [Related]
119. Inhibition of macrophages inflammasome activation
He M; Chu T; Wang Z; Feng Y; Shi R; He M; Feng S; Lu L; Cai C; Fang F; Zhang X; Liu Y; Gao B
Front Immunol; 2023; 14():1147379. PubMed ID: 37122751
[TBL] [Abstract][Full Text] [Related]
120. Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease 2019.
Tavakoli R; Rahimi P; Hamidi-Fard M; Eybpoosh S; Doroud D; Sadeghi SA; Zaheri Birgani M; Aghasadeghi M; Fateh A
Arch Med Res; 2023 Feb; 54(2):105-112. PubMed ID: 36621405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
